Lisa Beatty1,2, Emma Kemp3,4, Jane Turner5, Phyllis Butow6, Donna Milne7, Patsy Yates8, Sylvie Lambert9, Addie Wootten10, Bogda Koczwara3,4. 1. Flinders University, Adelaide, Australia. lisa.beatty@flinders.edu.au. 2. Flinders Medical Centre, Adelaide, Australia. lisa.beatty@flinders.edu.au. 3. Flinders University, Adelaide, Australia. 4. Flinders Medical Centre, Adelaide, Australia. 5. University of Queensland, Brisbane, Australia. 6. University of Sydney, Sydney, Australia. 7. Peter MacCallum Cancer Centre, Melbourne, Australia. 8. Queensland University of Technology, Brisbane, Australia. 9. McGill University, Montreal, Canada. 10. Smiling Mind, Abbotsford, Australia.
Abstract
PURPOSE: The present analysis explores whether demographic, psychosocial, or intervention adherence factors moderated treatment efficacy of Finding My Way (FMW), an efficacious self-directed web-based psychosocial program for newly diagnosed curatively treated cancer patients. METHODS:Participants (n = 191) completed a6-module intervention (n = 94) or attention-control (n = 97) program. Outcome measures were completed at baseline (T0), post-program (T1), 3-month (T2), and 6-month (T3) follow ups. Age, gender, social support, information processing style (monitoring vs blunting), emotion-regulation difficulties, and intervention adherence were examined as potential moderators. RESULTS:Age moderated emotional functioning and general distress at T3 with significant intervention benefits only observed in younger participants; age moderated cognitive functioning at T1, with intervention benefits only found in older participants. Gender moderated helplessness/hopelessness, emotional functioning, and cognitive avoidance at T1 with men benefitting more from receiving the intervention vs control. Monitoring information-processing style moderated cancer distress and anxious preoccupation at T3: higher monitors benefitted more from receiving the intervention vs control. Program adherence moderated global QOL, emotional functioning and social functioning at T2 and T3; cognitive avoidance (T1), anxious preoccupation (T2) and role function (T3), with those who completed more of the program benefitting more if they received the intervention than control. Emotion dysregulation and social support each moderated role function at T2, with those more dysregulated and less socially supported benefitting more if they received the intervention than control. CONCLUSIONS: For select outcomes, FMW is more effective for patients with specific characteristics; these findings can inform future tailoring and targeting of online programs for cancer-distress.
RCT Entities:
PURPOSE: The present analysis explores whether demographic, psychosocial, or intervention adherence factors moderated treatment efficacy of Finding My Way (FMW), an efficacious self-directed web-based psychosocial program for newly diagnosed curatively treated cancerpatients. METHODS:Participants (n = 191) completed a 6-module intervention (n = 94) or attention-control (n = 97) program. Outcome measures were completed at baseline (T0), post-program (T1), 3-month (T2), and 6-month (T3) follow ups. Age, gender, social support, information processing style (monitoring vs blunting), emotion-regulation difficulties, and intervention adherence were examined as potential moderators. RESULTS: Age moderated emotional functioning and general distress at T3 with significant intervention benefits only observed in younger participants; age moderated cognitive functioning at T1, with intervention benefits only found in older participants. Gender moderated helplessness/hopelessness, emotional functioning, and cognitive avoidance at T1 with men benefitting more from receiving the intervention vs control. Monitoring information-processing style moderated cancer distress and anxious preoccupation at T3: higher monitors benefitted more from receiving the intervention vs control. Program adherence moderated global QOL, emotional functioning and social functioning at T2 and T3; cognitive avoidance (T1), anxious preoccupation (T2) and role function (T3), with those who completed more of the program benefitting more if they received the intervention than control. Emotion dysregulation and social support each moderated role function at T2, with those more dysregulated and less socially supported benefitting more if they received the intervention than control. CONCLUSIONS: For select outcomes, FMW is more effective for patients with specific characteristics; these findings can inform future tailoring and targeting of online programs for cancer-distress.
Authors: Grietje Bouma; Jolien M Admiraal; Elisabeth G E de Vries; Carolien P Schröder; Annemiek M E Walenkamp; Anna K L Reyners Journal: Crit Rev Oncol Hematol Date: 2015-01-31 Impact factor: 6.312
Authors: Emma Vaughan; Bogda Koczwara; Emma Kemp; Corinna Freytag; Wilson Tan; Lisa Beatty Journal: Psychooncology Date: 2019-06-06 Impact factor: 3.894
Authors: Lisa Beatty; Emma Kemp; Joseph R Coll; Jane Turner; Phyllis Butow; Donna Milne; Patsy Yates; Sylvie Lambert; Addie Wootten; Desmond Yip; Bogda Koczwara Journal: Support Care Cancer Date: 2018-11-09 Impact factor: 3.603
Authors: Carolyn J Heckman; Elizabeth A Handorf; Susan D Darlow; Lee M Ritterband; Sharon L Manne Journal: Health Psychol Date: 2016-11-07 Impact factor: 4.267
Authors: Madelon B Bronner; Minh Hao Nguyen; Ellen M A Smets; Anthony W H van de Ven; Julia C M van Weert Journal: Psychooncology Date: 2017-10-26 Impact factor: 3.894
Authors: Corinne Urech; Astrid Grossert; Judith Alder; Sandra Scherer; Barbara Handschin; Benjamin Kasenda; Borislava Borislavova; Sven Degen; Jennifer Erb; Alexandra Faessler; Laura Gattlen; Sarah Schibli; Celine Werndli; Jens Gaab; Thomas Berger; Thomas Zumbrunn; Viviane Hess Journal: J Clin Oncol Date: 2018-01-25 Impact factor: 44.544
Authors: J Kalter; I M Verdonck-de Leeuw; M G Sweegers; N K Aaronson; P B Jacobsen; R U Newton; K S Courneya; J F Aitken; J Armes; C Arving; L J Boersma; A M J Braamse; Y Brandberg; S K Chambers; J Dekker; K Ell; R J Ferguson; M F M Gielissen; B Glimelius; M M Goedendorp; K D Graves; S P Heiney; R Horne; M S Hunter; B Johansson; M L Kimman; H Knoop; K Meneses; L L Northouse; H S Oldenburg; J B Prins; J Savard; M van Beurden; S W van den Berg; J Brug; L M Buffart Journal: Psychooncology Date: 2018-03-15 Impact factor: 3.894
Authors: Monica Leslie; Lisa Beatty; Lee Hulbert-Williams; Rosina Pendrous; Tim Cartwright; Richard Jackson; Nicholas J Hulbert-Williams Journal: JMIR Cancer Date: 2022-07-08